drugset / Trial / NCT02897726

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

NCT02897726 ↗

Phase 1 Completed 38 enrolled NVP Healthcare
RandomizedCrossoverOpen-labelScreening

Summary

The purpose of this study is to evaluate and compare the safety and pharmacokinetics of NVP-1402 and NVP-1402R in healthy male subjects.

Timeline

Start
2017-03-24
Primary completion
2017-07-03
Completion
2017-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject NVP-1402 Unknown — Oral
Comparator NVP-1402R Unknown — Oral

Indications

No indication recorded.